Mots-clés
 > MYOBASE > BIOLOGIE > biologie par discipline > physiologie > métabolisme > catabolisme > stress oxydatif > antioxydant
antioxydantSynonyme(s)anti-oxydant ;anti-oxidant antioxidants |
trié(s) par (Pertinence décroissant(e), Date de parution décroissant(e), Date de parution décroissant(e), Système de projection du document croissant(e)) Mettre toutes les notices dans le panier Faire une suggestion Ajouter un critère de rechercheEtendre la recherche sur niveau(x) vers le bas
Temporary Reduction of Membrane CD4 with the Antioxidant MnTBAP Is Sufficient to Prevent Immune Responses Induced by Gene Transfer
Da Rocha S, Bigot J, Onodi F, et al.
Molecular therapy. Methods & clinical development, 2019, 14, p 285
Antioxidant therapy for muscular dystrophy: caveat lector!
O'Halloran KD, Murphy KH, Burns DP
The Journal of physiology, 2018, 596, 4, p 737
Reply from Gavin J. Pinniger, Jessica R. Terrill, Miranda D. Grounds and Peter G. Arthur
Pinniger GJ, Terrill JR, Grounds MD, et al.
The Journal of physiology, 2018, 596, 4, p 739
Edaravone is a candidate agent for spinal muscular atrophy: In vitro analysis using a human induced pluripotent stem cells-derived disease model
Ando S, Funato M, Ohuchi K, et al.
European journal of pharmacology, 2017, 814, p 161
Sialic acid deficiency is associated with oxidative stress leading to muscle atrophy and weakness in the GNE myopathy
Cho A, Malicdan MCV, Miyakawa M, et al.
Human molecular genetics, 2017, 26, 16, p 3081
Antioxidant Treatment Reduces Formation of Structural Cores and Improves Muscle Function in RYR1(Y522S/WT) Mice
Michelucci A, De Marco A, Guarnier FA, et al.
Oxidative medicine and cellular longevity, 2017, 2017
Are Antioxidants a Potential Therapy for FSHD? A Review of the Literature
Denny AP, Heather AK
Oxidative medicine and cellular longevity, 2017, 2017
Dystrophic phenotype improvement in the diaphragm muscle of mdx mice by diacerhein
Mancio RD, Hermes TA, Macedo AB, et al.
PLoS ONE, 2017, 12, 8
Pre-clinical evaluation of N-acetylcysteine reveals side effects in the mdx mouse model of Duchenne muscular dystrophy
Pinniger GJ, Terrill JR, Assan EB, et al.
The Journal of physiology, 2017, 595, 23, p 7093
Impact d'un traitement antioxydant sur le transfert de gène par un vecteur AAVr dans un modèle murin de la dystrophie musculaire de Duchenne
Dupont JB, Tournaire B, Durand R, et al.
Les Cahiers de Myologie, 2016, 13, p. 99-101
Myology 2016 : 5th International Congress of Myology ; Posters n° 388 to 423 - Young Investigator Posters
Congrès : 5th International Congress of Myology (14-18 March 2016; Centre convention, Lyon, France)
2016, p. 205-222
A small-molecule Nrf1 and Nrf2 activator mitigates polyglutamine toxicity in spinal and bulbar muscular atrophy
Bott LC, Badders NM, Chen KL, et al.
Human molecular genetics, 2016, 25, 10, p 1979
The effects of resveratrol and SIRT1 activation on dystrophic cardiomyopathy
Kuno A, Tanno M, Horio Y
Annals of the New York Academy of Sciences, 2015, 1348, 1, p 46
Effects of vitamin C, vitamin E, zinc gluconate and selenomethionine supplementation on muscle function and oxidative stress biomarkers in patients with facioscapulohumeral dystrophy: a double-blind randomized controlled clinical trial
Passerieux E, Hayot M, Jaussent A, et al.
Free radical biology & medicine, 2015, 81, p 158
The role of oxidative stress in skeletal muscle injury and regeneration: focus on antioxidant enzymes
Kozakowska M, Pietraszek-Gremplewicz K, Jozkowicz A, et al.
Journal of muscle research and cell motility, 2015, 36, 6, p 377
FSH : résultats d'un essai de supplémentation en antioxydants
VLM. Vaincre les myopathies, 2014, 171, p. 18
Naturally occurring plant polyphenols as potential therapies for inherited neuromuscular diseases.
Fuller HR, Humphrey E, Morris GE
Future Medicinal Chemistry, 2013, 5, 17, p. 2091-101
Whither hope for pharmacological treatment of Charcot-Marie-Tooth disease type 1A ?
Patel PI, Pleasure D
JAMA Neurology, 2013, 70, 8, p. 969-971
Contribution of oxidative stress to pathology in diaphragm and limb muscles with Duchenne muscular dystrophy
Kim JH, Kwak HB, Thompson LV, et al.
Journal of muscle research and cell motility, 2013, 34, 1, p. 1-13
Dystrophie musculaire facio-scapulo-humérale : l’atteinte musculaire est associée à un stress oxydatif et un dysfonctionnement des mitochondries
Cukierman L
2012
Pre-clinical drug tests in the mdx mouse as a model of dystrophinopathies : an overview
de Luca A
Acta myologica, 2012, 31, 1, p. 40-47
Functional muscle impairment in facioscapulohumeral muscular dystrophy is correlated with oxidative stress and mitochondrial dysfunction
Turki A, Hayot M, Carnac G, et al.
Free radical biology and medicine, 2012, 53, 5, p. 1068-1079
